Nodexus Overview

  • Year Founded
  • 2014

Year Founded

  • Status
  • Private

  • Employees
  • 41

Employees

  • Latest Deal Type
  • Accelerator/​Inc

  • Investors
  • 19

Nodexus General Information

Description

Developer of microfluidic systems designed for the detection of metastatic cancer. The company's medical equipment offers affordable automated cell isolation for applications in industry, clinical research, and academia including cell line and antibody development, CRISPR engineering, single-cell genomics, and synthetic biology, enabling clients to accelerate biological workflows and make them more widely accessible.

Contact Information

Website
www.nodexus.com
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Primary Industry
Diagnostic Equipment
Other Industries
Biotechnology
Other Devices and Supplies
Corporate Office
  • 2130 Gold Street
  • Suite 100
  • San Jose, CA 95002
  • United States
+1 (510) 000-0000

Nodexus Timeline

2021202220232024
Financing RoundCaptured Employee CountEstimated Employee Growth

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Nodexus Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
13. Accelerator/Incubator 000.00 Completed Generating Revenue
12. Later Stage VC (Series A) 16-Dec-2021 0000 000.00 0000 Completed Generating Revenue
11. Accelerator/Incubator 01-Oct-2020 00.00 Completed Generating Revenue
10. Grant 01-Sep-2020 00.000 00.00 Completed Generating Revenue
9. Grant 20-Sep-2019 00000 00.00 Completed Generating Revenue
8. Grant 31-Dec-2018 00000 00.00 Completed Generating Revenue
7. Secondary Transaction - Private 00.00 Completed Generating Revenue
6. Accelerator/Incubator 01-Sep-2017 00.00 Completed Generating Revenue
5. Grant 31-Dec-2015 $100K $2.9M Completed Startup
4. Early Stage VC (Series A) 01-Jan-2015 $2.9M $2.9M 000.00 Completed Startup
To view Nodexus’s complete valuation and funding history, request access »

Nodexus Cap Table

Stock # of Shares
Authorized
Par Value Dividend Rate (%) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion Price % Owned
Series A 00,000,000 00.000000 00.00 00.00 00 00.00 00.000
Series A-2 0,000,000 00.000000 00.00 00.00 00 00.00 0.000
Series A-1 3,623,905 $0.000100 $0.47 $0.47 1x $0.47 6.85%
To view Nodexus’s complete cap table history, request access »

Nodexus Patents

Nodexus Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
US-11579073-B2 Microfluidic system with combined electrical and optical detection for high accuracy particle sorting and methods thereof Active 07-Feb-2017 00000000000 00
US-20200096436-A1 Microfluidic system with combined electrical and optical detection for high accuracy particle sorting and methods thereof Active 07-Feb-2017 00000000000
EP-3579973-A1 Microfluidic system with combined electrical and optical detection for high accuracy particle sorting and methods thereof Pending 07-Feb-2017 00000000000
US-20220283078-A1 Microfluidic system with combined electrical and optical detection for high accuracy particle sorting and methods thereof Active 07-Feb-2017 000000000000 0
EP-3579973-A4 Microfluidic system with combined electrical and optical detection for high accuracy particle sorting and methods thereof Pending 07-Feb-2017 G01N15/1484 0
To view Nodexus’s complete patent history, request access »

Nodexus Executive Team (5)

Name Title Board Seat Contact Info
Karthik Balakrishnan Ph.D Co-Founder, Chief Executive Officer & Board Member
Anand Kesavaraju Co-Founder, Chief Strategy Officer & Board Member
Hany Nassef Ph.D Vice President, Engineering
William Rhodes Executive Chairman, Independent
You’re viewing 4 of 5 executive team members. Get the full list »

Nodexus Board Members (7)

Name Representing Role Since
Anand Kesavaraju Nodexus Co-Founder, Chief Strategy Officer & Board Member 000 0000
Fuad Naser Ph.D RA Capital Management Board Member 000 0000
Jonathan Lundt Ph.D RA Capital Management Board Observer 000 0000
Karthik Balakrishnan Ph.D Nodexus Co-Founder, Chief Executive Officer & Board Member 000 0000
Michael Pellini MD S32 Board Member 000 0000
You’re viewing 5 of 7 board members. Get the full list »

Nodexus Signals

Growth Rate

0.80% Weekly
Growth
Weekly Growth 0.80%, 93rd %
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers

5.5k

Similarweb Unique Visitors

15.0K

Majestic Referring Domains

314

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Nodexus Investors (19)

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info
Linden3 Ventures Venture Capital Minority 000 0000 000000 0
RA Capital Management Venture Capital Minority 000 0000 000000 0
S32 Venture Capital Minority 000 0000 000000 0
Samudra Pacific Capital Partners Venture Capital Minority 000 0000 000000 0
William Rhodes Angel (individual) Minority 000 0000 000000 0
You’re viewing 5 of 19 investors. Get the full list »

Nodexus FAQs

  • When was Nodexus founded?

    Nodexus was founded in 2014.

  • Who is the founder of Nodexus?

    Karthik Balakrishnan Ph.D, Anand Kesavaraju, and Vincent Tuminelli are the founders of Nodexus.

  • Who is the CEO of Nodexus?

    Karthik Balakrishnan Ph.D is the CEO of Nodexus.

  • Where is Nodexus headquartered?

    Nodexus is headquartered in San Jose, CA.

  • What is the size of Nodexus?

    Nodexus has 41 total employees.

  • What industry is Nodexus in?

    Nodexus’s primary industry is Diagnostic Equipment.

  • Is Nodexus a private or public company?

    Nodexus is a Private company.

  • What is Nodexus’s current revenue?

    The current revenue for Nodexus is 00000.

  • How much funding has Nodexus raised over time?

    Nodexus has raised $32.9M.

  • Who are Nodexus’s investors?

    Linden3 Ventures, RA Capital Management, S32, Samudra Pacific Capital Partners, and William Rhodes are 5 of 19 investors who have invested in Nodexus.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read blog »
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process »